New York Gives Final Approval for Rosetta Genomics' miRview Lung Assay
November 06, 2012
New York Gives Final Approval for Rosetta Genomics' miRview Lung Assay
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Rosetta to Offer $35M in Public Offering, Receives NYS Approval for Lung Cancer Assay
June 26, 2012 / GenomeWeb Daily News - Rosetta Publishes Data on microRNA-Based Lung Cancer Assay
July 5, 2012 / Gene Silencing News - Rosetta Genomics, UC Davis Partner on Patient Response to Bladder Cancer Treatment
June 28, 2011 / GenomeWeb Daily News - Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News - Sanra Labs Makes Full Payment to Rosetta Genomics, Settling Dispute
May 10, 2013 / GenomeWeb Daily News